Generated by All in One SEO v5.0.0.1, this is an llms.txt file, used by LLMs to index the site.

# BlossomHill Therapeutics

The Next Leap Forward in Precision Cancer Medicine

## Sitemaps

- [XML Sitemap](https://bhtherapeutics.com/sitemap.xml): Contains all public & indexable URLs for this website.

## Pages

- [Contact](https://bhtherapeutics.com/contact/) - Interested in learning more about our pipeline or joining our team? Get in touch with us.
- [Sitemap](https://bhtherapeutics.com/sitemap/)
- [Cookie Policy](https://bhtherapeutics.com/cookie-policy/) - Cookie Policy for BlossomHill Therapeutics
- [Terms of Service](https://bhtherapeutics.com/terms-of-service/) - Terms of Service for BlossomHill Therapeutics
- [Privacy Policy](https://bhtherapeutics.com/privacy-policy/) - Privacy Policy for BlossomHill Therapeutics
- [Footer](https://bhtherapeutics.com/footer/)
- [Careers](https://bhtherapeutics.com/careers/) - Our team combines human intelligence, creative thinking and a proven track record of developing innovating small molecule medicines that overcome the limitations of existing therapies.
- [Patients](https://bhtherapeutics.com/patients/) - BlossomHill Therapeutics is committed to advancing innovative precision medicines for people living with cancer. We are focused on developing transformative targeted therapies designed to address the complex and evolving needs of patients, including those with limited treatment options.
- [BH-501284](https://bhtherapeutics.com/pipeline/bh-501284/) - BH-501284 is an investigational, orally bioavailable pan-KRAS inhibitor, which utilizes a novel Switch-II chemical scaffold in an effort to achieve prolonged, potent and selective inhibition of KRAS mutations.
- [BH-30236](https://bhtherapeutics.com/pipeline/bh-30236/) - BH-30236 is an investigational orally bioavailable, macrocyclic inhibitor of the CDC-like kinase family.
- [BH-30643](https://bhtherapeutics.com/pipeline/bh-30643/) - BH-30643 is an investigational non-covalent, macrocyclic, brain active, mutant-selective OMNI-EGFRTM inhibitor which has demonstrated sub-nanomolar cellular in vitro potency against a broad spectrum of EGFR activating mutations.
- [Pipeline](https://bhtherapeutics.com/pipeline/) - Each of our programs represents the application of our approach to a distinct target biology and patient populations with significant unmet medical need.
- [About Us](https://bhtherapeutics.com/about-us/) - Our drug design philosophy is meticulous, deliberate and artistic, with each small molecule exquisitely crafted for selectivity, durability and safety.
- [Home](https://bhtherapeutics.com/home/) - We are on a mission to exponentially improve the number of quality years for patients.
- [Investors](https://bhtherapeutics.com/investors/)

## Team

- [Sundeep Agrawal, M.D.](https://bhtherapeutics.com/team/sundeep-agrawal/)
- [Sheila Gujrathi, M.D.](https://bhtherapeutics.com/team/sheila-gujrathi/)
- [John Schmid](https://bhtherapeutics.com/team/john-schmid/)
- [Carl L. Gordon, Ph.D., CFA](https://bhtherapeutics.com/team/carl-l-gordon/)
- [Bihua Chen](https://bhtherapeutics.com/team/bihua-chen/)
- [Zachary F. Zimmerman, M.D., Ph.D.](https://bhtherapeutics.com/team/zachary-f-zimmerman/)
- [Diane Wang, Ph.D.](https://bhtherapeutics.com/team/diane-wang/)
- [Jill Stuart Smith, MBA](https://bhtherapeutics.com/team/jill-stuart-smith/)
- [Z. Jesse Shao, Ph.D., R.Ph.](https://bhtherapeutics.com/team/jesse-shao/)
- [Eugene Y. Rui, Ph.D.](https://bhtherapeutics.com/team/eugene-y-rui/)
- [Ashley Preston, Ph.D.](https://bhtherapeutics.com/team/ashley-preston/)
- [Antonio Garrido-Montalban, Ph.D.](https://bhtherapeutics.com/team/antonio-garrido-montalban/)
- [Jason Keyes, MBA](https://bhtherapeutics.com/team/jason-keyes/)
- [Vincent Liptak, J.D., Ph.D., MBA](https://bhtherapeutics.com/team/vincent-liptak/)
- [Geoff Oxnard, M.D.](https://bhtherapeutics.com/team/geoff-oxnard/)
- [Y. Peter Li, Ph.D., MBA](https://bhtherapeutics.com/team/y-peter-li/)
- [J. Jean Cui, Ph.D.](https://bhtherapeutics.com/team/j-jean-cu/)

## Portfolio Categories

- [Leadership](https://bhtherapeutics.com/team/leadership/)
- [Board of Directors](https://bhtherapeutics.com/team/board-of-directors/)